SCHEMBL7388153

SCHEMBL7388153

COc1cc(CCC(C)(C)[Si](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)CCc2cc(OC)cc(OC)c2)(c2ccccc2)c2ccccc2)cc(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.40
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
ABCB1 P08183 2/20 0.38
CALM1 P0DP23 5/20 0.38
AKR1B1 P15121 2/20 0.38
MAOB P27338 1/20 0.36
FGFR1 P11362 2/20 0.35
KDR P35968 1/20 0.35
TACR1 P25103 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR3 P22607 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8862091 0.77 TDP1 (0.49) CALM1L3MBTL1
SCHEMBL8862044 0.77 TDP1 (0.49) CALM1L3MBTL1
SCHEMBL7795405 0.77 TAAR1 (0.35)
SCHEMBL532667 0.77 MAOB (0.46) CYP19A1MAOBL3MBTL1
SCHEMBL5782201 0.74 ABCB1 (0.43) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1754326 0.70 CYP19A1 (0.50) CYP19A1GABRA1GABRG2GABRB3GABRA3
SCHEMBL1972535 0.70 CYP19A1 (0.66) CYP19A1GABRA1GABRG2GABRB3GABRA3
SCHEMBL5574146 0.70 CYP3A4 (0.41) TSHRL3MBTL1
SCHEMBL5236553 0.70 CA4 (0.40) TSHRMAPK1ABCB1MAOB
SCHEMBL7191335 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed